First, antitrust originators who can move merger-control and civil-conduct relationships without a total conflicts wipeout. Second, white-collar and investigations partners with corporate-crisis ownership and trial readiness. Third, regulatory and compliance partners who bridge financial-services, healthcare or technology sector rules. Fourth, energy and natural-resources partners spanning FERC, project development and environmental enforcement. Fifth, healthcare and life-sciences partners with False Claims Act defence or FDA counselling depth.
Pirical's Q1 2026 city ranking put Washington, DC at 126 partner hires and New York City at 203, with litigation (388) and corporate (217) as the densest practice counts among Am Law 200 partner moves that quarter. Law.com reported in 2026 that hires from government positions accounted for 7% of Am Law 200 laterals in 2025, up from 4% in 2024—a capital-market pulse that feeds partner and counsel seats after administration and agency turnover. That public picture matches what our Washington mandate telemetry records on the 22 closed partner searches of the last three years: roughly 55% of completed files were antitrust, white-collar or regulatory, about 25% healthcare, life sciences or energy, and the balance government contracts or mixed-practice builds.
Live confidential work (client-side) typically includes Am Law 50–100 single-partner adds in District antitrust and investigations, regulatory platform builds for national firms deepening Washington, and energy or healthcare partners for sector-concentrated books. Candidate-side interest is highest among partners whose originations have outgrown current platform credit, who need equity-path clarity after nonequity years, or who face an investigation wall that a different firm can clear. Absolute volume is high; underwriting still decides who actually moves.